跳至主要内容
临床试验/NCT04312477
NCT04312477Unknown早期 1 期

The Correlation Within Diarrhea-predominant Irritable Boewl Syndrome(IBS-D) and Intestinal Microbiota Via C1orf106/Cytohesin-1(CYTH-1) /Adenosine Diphosphate-ribosylation Factor 6(ARF6) Signal Pathway and the Intervention Mechanism of Classic Chinese Compound Formula With Clearing Heat and Promoting Dieresis

Xiyuan Hospital of China Academy of Chinese Medical Sciences1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2019年4月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
入组人数
60
试验地点
1
主要终点
IBS symptom severity (IBS-SSS)scale

研究概览

简要总结

Diarrhea-predominant irritable boewl syndrome(IBS-D) seriously affect the quality of life in patients. Clinically, it is effective to apply therapeutic method of clearing heat and promoting diuresis to the common syndrome of dampness-heat. Dysbiosis of intestinal microbiota is closely related to the immune imbalance and intestinal mucosal barrier injury. C1orf106/CYTH-1/ARF6 signal pathway, which derive from intestinal micro environment changes,is the mainly cause of intestinal mucosal barrier injury, and this is may be the common pathogenesis of dampness-heat syndrome in IBS-D . Based on the clinic, the project is to study the effect and mechanism of Chinese compound formula of clearing heat and promoting dieresis in modulating intestinal microbiota dysbiosis, repairing intestinal mucosal barrier and reconstructing intestinal microenvironment. With the combination of metagenomics and metabonomics, the study compare the differences of co-metabolites of intestinal microbiota and host within the healthy people, IBS-D patients with dampness-heat syndrome, to explore the relevance between intestinal flora and host co-metabolites. Furthermore, the experimental study is to clarify the drug targets via C1orf106/ CYTH-1/ARF6 signal pathway.Through the study of association between dampness-heat syndrome in IBS-D and intestinal microbiota, it is of important academic significance to reveal the Chinese theory intension of "homotherapy for heteropathy ".

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • It meets the diagnostic criteria of diarrhea-predominant irritable boewl syndrome and meets the diagnostic criteria for damp-heat syndrome.
  • Age between 18 and 70 years old.
  • Not taking antibiotics, steroids and other hormones, Chinese herbal preparations in the past week (including) Probiotics such as oral and intravenous), microecological preparations or yogurt.
  • The subject informed and voluntarily signed the informed consent form. ;
  • Have a certain reading ability

排除标准

  • Patients with severe organ, liver, kidney and other major organ diseases, hematopoietic system, nervous system or mental illness;
  • combined with other digestive systemic lesions (such as peptic ulcer), or systemic diseases affecting digestive tract motility (eg hyperthyroidism, diabetes);
  • Those who are or need to continue to use drugs that may affect gastrointestinal function (antidiarrheals, antidepressants, anxiolytics, intestinal flora regulators, antibiotics, etc.);
  • Those with a history of allergic reactions to related drugs and a history of severe food allergies.

研究组 & 干预措施

Experimental group

Experimental

Modified Gegen Qinlian Decoction, Oral, 7.2g per bag, 2 times / day, 30 minutes before breakfast and dinner

干预措施: Modified Gegen Qinlian Decoction (Drug)

Control group

Active Comparator

Bifico(Bifidobacterium triple viable capsule), orally,2 capsules/time, 2 days/time.

干预措施: Modified Gegen Qinlian Decoction (Drug)

结局指标

主要结局

IBS symptom severity (IBS-SSS)scale

时间窗: Change from Baseline disease activity at 4weeks

The IBS-SSS scale is scored from five aspects: the degree of abdominal pain, the frequency of abdominal pain, the degree of bloating, the degree of defecation satisfaction, and the impact on life.Each score is 0-100 points, and the total score is IBS-SSS scores from the degree of abdominal pain, the frequency of abdominal pain, the degree of abdominal distention, the satisfaction of defecation and the impact on life. Each score is 0-100, and the total score is 0-500. The higher the score, the more serious the disease is.

The Clinical Global Impression of severity Scale ( CGI-S)

时间窗: 4 weeks

次要结局

  • Bristol Stool Form Scale(4 weeks)
  • PRO scale(4 weeks)
  • The scores of TCM(Traditional Chinese Medicine) syndrome(4 weeks)
  • The short form 36 (SF-36) health survey questionnaire(4 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验